We held a voting session during our HONEUR Forum meeting on 23 September, and are delighted to inform you all that our HONEUR Working Charter has been officially released! Our Working Charter...

HONEUR has sent out its very first HONEUR Newsletter! In this edition: 19 HONEUR data partners 2022 News and milestones: current studies, publications, and new capabilities HONEUR governance model...

Have a look at our first publication: “The Value of Federated Data Networks in Oncology: What Research Questions Do They Answer? Outcomes From a Systematic Literature Review.” In this paper, we...

We are proud to inform you about our latest publication: “Haematology Outcomes Network in Europe (HONEUR)—A collaborative, interdisciplinary platform to harness the potential of real-world data in...

We are delighted to share that four data partners have joined the network, from four different countries! Tel Aviv Sourasky Medical Center – Israel Tel Aviv Sourasky Medical Center's division of...

We are proud to share with you that we currently have over 23.000 patients from 7 HONEUR sites mapped in the HONEUR network. Nearly 17.000 are in multiple myeloma. We also now have over 4.000 CLL...

ITEM CODE: RF-251515 | DATE OF PREPARATION: JANUARI 2023

ITEM CODE: RF-251517 | DATE OF PREPARATION: JANUARY 2023

This site is published by Janssen Pharmaceutica N.V., which is solely responsible for its content. This site is intended for the use of our visitors in Europe, the Middle East and Africa. Last...

ITEM CODE: RF-272618 | DATE OF PREPARATION: 28 JUNE 2023

We are delighted to inform you that our HONEUR Project Lead, Kristina Bardenheuer, was invited for an interview with The Evidence Base®, on HONEUR and Federated Data Networks. Kristina explained...

It is with great pride that we look back at our very first HONEUR Forum meeting, which was held on 23 September 2022. A special thanks to our external speakers and hybrid audience who contributed...

We would like to share a moment of pride and accomplishment as our HONEUR (Haematological Outcomes Network in Europe) analysis with title “Real-World Patient Characteristics and Survival Outcomes...

Exciting News! Our second hybrid HONEUR Forum, organized on 25-26 May 2023 in Amsterdam was a success!

Our 2023 HONEUR Summer Newsletter has been sent out. In this edition you can find an update on our ongoing and planned evidence-generation projects, a recap of our recent HONEUR Forum meeting in...

Thrilled to share the news of our upcoming fourth HONEUR Forum meeting in the picturesque city of Rome, Italy, on March 20-21, 2024! Calling upon our esteemed HONEUR Data Partners and potential...

In collaboration with our HONEUR Data partner Cancer Centre London, we published an abstract in Blood, entitled “An Honeur Framework for Generating Computer Understandable Cohort Definitions from...

We have shared our 2023 Winter HONEUR Newsletter. This edition features: 23 HONEUR data partners, with CHU Nice and Policlinico di Milano as our newest members: CHU de Nice The hematology...

We are delighted to introduce to you our 24th HONEUR data partner: ASST Ovest Milanese. The Hospital Healthcare company Ovest Milanese is a public organization which include 4 entities in an area...

ITEM CODE: RF-402052 | DATE OF PREPARATION: 12 FEBRUARY 2024